Join
Live feed
·
INSIDERFilingvia Quantisnow
Intensity Therapeutics Inc. logo

Chief Financial Officer Talamo Joseph was granted 1,093 shares, increasing direct ownership by 95% to 2,239 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INTS· Intensity Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INTS (Intensity Therapeutics Inc.) and more on Quantisnow.